companydata.dkACESION PHARMA ApS: Financial statements 2013
CVR: 34083738
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -4,833,419 and a net result of DKK -6,507,161 compared with DKK -2,068,513 the year before. Equity amounted to DKK -555,682.
- Gross Profit
- -4,833,419 kr.
- Profit/Loss
- -6,507,161 kr.
- Equity
- -555,682 kr.
- Total Assets
- 9,056,025 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -4.8 mio. | -6.5 mio. | -556 t. | - |
| 2012 | - | -1.3 mio. | -2.1 mio. | 2 mio. | - |
Find more companies like ACESION PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
ACESION PHARMA ApS has published its annual report for 2012. Gross profit came to DKK -1,313,935, and the net result was DKK -2,068,513.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees. In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity amounted to DKK 276,067,000.